216 related articles for article (PubMed ID: 26224332)
21. Evolution of the therapeutic drug monitoring of cyclosporine.
Citterio F
Transplant Proc; 2004 Mar; 36(2 Suppl):420S-425S. PubMed ID: 15041378
[TBL] [Abstract][Full Text] [Related]
22. Single time point measurement by C2 or C3 is highly predictive in cyclosporine area under the curve estimation immediately after lung transplantation.
Hangler HB; Ruttmann E; Geltner C; Bucher B; Nagiller J; Laufer G; Mueller LC
Clin Transplant; 2008; 22(1):35-40. PubMed ID: 18217903
[TBL] [Abstract][Full Text] [Related]
23. New concepts in cyclosporine monitoring.
Keown PA
Curr Opin Nephrol Hypertens; 2002 Nov; 11(6):619-26. PubMed ID: 12394607
[TBL] [Abstract][Full Text] [Related]
24. Applicability of a Single Time Point Strategy for the Prediction of Area Under the Concentration Curve of Linezolid in Patients: Superiority of Ctrough- over Cmax-Derived Linear Regression Models.
Srinivas NR; Syed M
Drugs R D; 2016 Mar; 16(1):69-79. PubMed ID: 26747454
[TBL] [Abstract][Full Text] [Related]
25. C2 single-point sampling to evaluate cyclosporine exposure in long-term renal transplant recipients.
Citterio F; Scatà MC; Borzi MT; Pozzetto U; Castagneto M
Transplant Proc; 2001; 33(7-8):3133-6. PubMed ID: 11750347
[No Abstract] [Full Text] [Related]
26. Two-hour postdose concentration: a reliable marker for cyclosporine exposure in adolescents with stable renal transplants.
John U; Ullrich S; Roskos M; Misselwitz J
Transplant Proc; 2005 Apr; 37(3):1608-11. PubMed ID: 15866686
[TBL] [Abstract][Full Text] [Related]
27. Differences in the Prediction of Area Under the Curve for a Protease Inhibitor Using Trough Versus Peak Concentration: Assessment Using Published Pharmacokinetic Data for Indinavir.
Srinivas NR
Am J Ther; 2017; 24(4):e405-e418. PubMed ID: 26291590
[TBL] [Abstract][Full Text] [Related]
28. Cyclosporine therapeutic monitoring with Cmax in kidney transplant recipients: does it fit for all populations?
El-Agroudy AE; Ismail AM; Nassar M; Ghoneim MA
Exp Clin Transplant; 2008 Dec; 6(4):282-6. PubMed ID: 19338490
[TBL] [Abstract][Full Text] [Related]
29. A limited sampling strategy for estimating mycophenolic acid area under the curve in adult heart transplant patients treated with concomitant cyclosporine.
Pawinski T; Kunicki PK; Sobieszczanska-Malek M; Gralak B; Szlaska I
J Clin Pharm Ther; 2009 Feb; 34(1):89-101. PubMed ID: 19125907
[TBL] [Abstract][Full Text] [Related]
30. Study of cyclosporine level at 2 hours after administration in preoperative kidney transplant recipients for prediction of postoperative optimal cyclosporine dose.
Sukhavasharin N; Praditpornsilpa K; Avihingsanon Y; Kuoatawintu P; O-Charoen R; Kansanabuch T; Tungsanga K; Eiam-Ong S
J Med Assoc Thai; 2006 Aug; 89 Suppl 2():S15-20. PubMed ID: 17044449
[TBL] [Abstract][Full Text] [Related]
31. Cyclosporine and sirolimus pharmacokinetics and drug-to-drug interactions in kidney transplant recipients.
Felipe CR; Park SI; Pinheiro-Machado PG; Garcia R; Casarini DE; Moreira S; Tedesco-Silva H; Medina-Pestana JO
Fundam Clin Pharmacol; 2009 Oct; 23(5):625-31. PubMed ID: 19656203
[TBL] [Abstract][Full Text] [Related]
32. Population pharmacokinetics and bayesian estimator of cyclosporine in pediatric renal transplant patients.
Irtan S; Saint-Marcoux F; Rousseau A; Zhang D; Leroy V; Marquet P; Jacqz-Aigrain E
Ther Drug Monit; 2007 Feb; 29(1):96-102. PubMed ID: 17304156
[TBL] [Abstract][Full Text] [Related]
33. Population pharmacokinetics and Bayesian estimation of cyclosporine in a Tunisian population of hematopoietic stem cell transplant recipient.
Eljebari H; Gaies E; Fradj NB; Jebabli N; Salouage I; Trabelsi S; Lakhal M; Klouz A
Eur J Clin Pharmacol; 2012 Nov; 68(11):1517-24. PubMed ID: 22527344
[TBL] [Abstract][Full Text] [Related]
34. Limited Sampling Strategy for the Prediction of Area Under the Curve (AUC) of Statins: Reliability of a Single Time Point for AUC Prediction for Pravastatin and Simvastatin.
Srinivas NR
Drug Res (Stuttg); 2016 Feb; 66(2):82-93. PubMed ID: 26011815
[TBL] [Abstract][Full Text] [Related]
35. A limited sampling strategy for the estimation of Neoral AUCs in pediatric patients.
Meier-Kriesche HU; Bonilla-Felix MA; Ferris ME; Swinford R; Kahan BD; Brannan P; Portman RJ
Pediatr Nephrol; 1999 Nov; 13(9):742-7. PubMed ID: 10603112
[TBL] [Abstract][Full Text] [Related]
36. Therapeutic drug monitoring of mycophenolic acid in kidney transplant patients: a abbreviated sampling strategy.
Muller H; Solari S; Zuniga C; Guerra I; Troncoso J; Ovalle R; Morente J; Pedreros C
Transplant Proc; 2007 Apr; 39(3):596-9. PubMed ID: 17445553
[TBL] [Abstract][Full Text] [Related]
37. Validation of sparse sampling strategies to estimate cyclosporine A area under the concentration-time curve using either a specific radioimmunoassay or high-performance liquid chromatography method.
Koristkova B; Grundmann M; Brozmanova H; Perinova I; Safarcik K
Ther Drug Monit; 2010 Oct; 32(5):586-93. PubMed ID: 20683391
[TBL] [Abstract][Full Text] [Related]
38. Limited sampling model for advanced mycophenolic acid therapeutic drug monitoring after liver transplantation.
Langers P; Press RR; Inderson A; Cremers SC; den Hartigh J; Baranski AG; van Hoek B
Ther Drug Monit; 2014 Apr; 36(2):141-7. PubMed ID: 24081208
[TBL] [Abstract][Full Text] [Related]
39. Safety and efficacy of generic cyclosporine arpimune in Filipino low-risk primary kidney transplant recipients.
Pamugas GE; Danguilan RA; Lamban AB; Mangati VB; Ona ET
Transplant Proc; 2012 Jan; 44(1):101-8. PubMed ID: 22310590
[TBL] [Abstract][Full Text] [Related]
40. Therapeutic drug monitoring of cyclosporine Neoral in de novo Chinese cardiac transplant recipients treated with an everolimus-cyclosporine immunosuppressive regimen.
Wang CH; Chou NK; Wu FL; Ko WJ; Tsao CI; Chi NH; Hsu RB; Wang SS
Transplant Proc; 2006 Sep; 38(7):2132-4. PubMed ID: 16980022
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
